Answers are grounded in this paper and cite their sources.
Background Sarcopenia is associated with adverse outcomes in interstitial lung disease (ILD). Bioelectrical impedance-derived phase angle (PhA) offers a repeatable measure of muscle quality, with lower PhA associated with greater frailty. Whether PhA is associated with clinical outcomes in ILD after accounting for muscle mass remains unknown. Methods In a prospective multicentre cohort study of 364 adults with ILD, PhA was assessed against sarcopenia-related domains. Mutually adjusted associations of PhA and appendicular skeletal muscle index (ASMI) with concurrent % predicted forced vital capacity (%FVC), 6-min walk distance (6MWD) and frailty, as well as longitudinal waitlist delisting or death, were evaluated using serial linear, logistic and Cox regression, as appropriate. Results After adjusting for ASMI, each 1- sd worsening in PhA was associated with lower %FVC (−2.9%, 95% CI −5.0– −0.7) and shorter 6MWD (−28.9 m, 95% CI −44.5– −13.4). Worsening PhA was associated with increased odds of frailty by Short Physical Performance Battery (OR 1.8, 95% CI 1.3–2.5) and Fried Frailty Phenotype (OR 1.8, 95% CI 1.2–2.7) and risk of waitlist delisting or death (hazard ratio (HR) 2.0, 95% CI 1.2–3.1). After adjusting for PhA, associations between ASMI and outcomes other than pulmonary function were no longer statistically significant. Conclusions Poor muscle quality, rather than muscle mass alone, may be an important risk factor for worse functional outcomes and survival in ILD. PhA provides a scalable measure of muscle quality in clinical and research settings and may identify patients at higher risk of functional decline and death.
No takes yet. Share an insight, caveat, or question.
Curnow et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: